Beach Investment Counsel Incpa Lowers stake in Henry Schein (HSIC)

Henry Schein (HSIC) : Beach Investment Counsel Incpa reduced its stake in Henry Schein by 47.6% during the most recent quarter end. The investment management company now holds a total of 15,316 shares of Henry Schein which is valued at $2,417,324 after selling 13,915 shares in Henry Schein , the firm said in a disclosure report filed with the SEC on Nov 14, 2016.Henry Schein makes up approximately 0.30% of Beach Investment Counsel Incpa’s portfolio.

Other Hedge Funds, Including , Congress Asset Management Co boosted its stake in HSIC in the latest quarter, The investment management firm added 35,451 additional shares and now holds a total of 278,040 shares of Henry Schein which is valued at $43,883,053. Henry Schein makes up approx 0.97% of Congress Asset Management Co’s portfolio.Teacher Retirement System Of Texas reduced its stake in HSIC by selling 2,680 shares or 45.27% in the most recent quarter. The Hedge Fund company now holds 3,240 shares of HSIC which is valued at $501,746.Capital One National Association reduced its stake in HSIC by selling 419 shares or 0.9% in the most recent quarter. The Hedge Fund company now holds 46,159 shares of HSIC which is valued at $6,886,923. Henry Schein makes up approx 0.56% of Capital One National Association’s portfolio.

Henry Schein closed down -1.93 points or -1.21% at $156.96 with 13,82,512 shares getting traded on Monday. Post opening the session at $158.33, the shares hit an intraday low of $156.68 and an intraday high of $158.87 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Henry Schein reported $1.68 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Nov 2, 2016. Analyst had a consensus of $1.65. The company had revenue of $2865.15 million for the quarter, compared to analysts expectations of $2877.72 million. The company’s revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.55 EPS.

Many Wall Street Analysts have commented on Henry Schein. Shares were Downgraded by Robert W. Baird on Oct 14, 2016 to ” Neutral” and Lowered the Price Target to $ 164 from a previous price target of $176 .Henry Schein was Upgraded by Goldman to ” Buy” on Oct 11, 2016. Henry Schein was Initiated by BofA/Merrill to “Buy” on Sep 12, 2016.

Henry Schein Inc. provides health care products and services to office-based dental animal health and medical practitioners. The Company operates its business through two segments: health care distribution and technology and value-added services. The health care distribution segment distributes consumable products laboratory products equipment repair services branded and generic pharmaceuticals vaccines surgical products diagnostic tests infection-control products and vitamins among others. The Company’s global technology and value-added services segment provides software technology and other value-added services to health care practitioners. Its offerings include practice management software systems for dental and medical practitioners and animal health clinics. Its value-added practice solutions include financial services on a non-recourse basis e-services practice technology network and hardware services as well as continuing education services for practitioners.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Henry Schein - Is it time to Sell?

Top Brokerage Firms are advising their investors on Henry Schein. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.